Full Name
Sallie R. Permar, MD, PhD
New York-Presbyterian/Weill Cornell Medical Center
Speaker Bio
Dr. Sallie Permar is the Nancy C. Paduano Professor and Chair of the Department of Pediatrics at Weill Cornell Medicine and Pediatrician-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center. She is also Professor of Immunology and Microbial Pathogenesis at the Weill Cornell Graduate School of Medical Sciences.

As a physician-scientist focusing on the prevention and treatment of neonatal viral infections, Dr. Permar leads a research laboratory investigating immune protection against vertical transmission of neonatal viral pathogens, namely HIV and cytomegalovirus (CMV). She has made important contributions to the development of vaccines for prevention of vertical HIV transmission, defining both innate and adaptive immune responses that are associated with protection against infant HIV acquisition. Moreover, Dr. Permar is leading the development of HIV vaccine strategies in preclinical maternal/infant nonhuman primate models and translation of this work for clinical vaccine trials in infants. Dr. Permar has also defined determinants of congenital and perinatal CMV transmission, developing the first nonhuman primate model of congenital CMV infection and leading human cohort studies that have defined immune correlates of protection necessary to guide vaccine development.

Dr. Permar has a Ph.D. in Microbiology/Immunology from Johns Hopkins Bloomberg School of Public Health in Baltimore, an M.D. from Harvard Medical School and completed her clinical training in pediatric infectious diseases at Children’s Hospital in Boston. She has received several prestigious investigator awards, including the Presidential Early Career Award in Science and Engineering (PECASE), and the E. Mead Johnson Award from the Society of Pediatric Research. She has been inducted into the American Society of Clinical Investigation (ASCI) and is a Fellow of the American Academy of Microbiology (AAM) and the American Association of Advancement of Science. In 2020, she received the Oswald Avery Award for Early Achievement from the Infectious Diseases Society of America and in 2022, Dr. Permar received the Excellence in Science Mid-Career Investigator Award from the Federation of American Societies for Experimental Biology (FASEB). She serves on the board of the National CMV Foundation and is an institutional and national leader in physician-scientist training, serving as the Director of the National Institute of Child Health and Development (NICHD) Pediatric Scientist Development Program.
Sallie R. Permar, MD, PhD